Please login to the form below
neurology
This page shows the latest neurology news and features for those working in and with pharma, biotech and healthcare.
Novartis files for approval of MS drug in EU, US
In the EXPAND study presented at this year’s American Academy of Neurology (AAN) conference, siponimod showed a 14-20% reduced risk of disability progression in SPMS compared to placebo at
Latest news
-
Daily Brief: Summit's $12m lifeline, Biohaven's speech anxiety pill, Crescendo's Humabody progress
The US specialist pharma company has acquired rights to a wide-range of neurology candidates from other companies, aiming to bring them to market in niche setttings.
-
Daily Brief: Sarepta deepens gene therapy investment, NICE changes mind on Besponsa, Digital Medicine company Akili raises $13m
Akili says its immersive video games have the potential to treat a wide range of medical conditions across neurology and psychiatry.
-
Axovant licenses another gene therapy as new strategy beds in
In neurology that includes a number of serious neurodegenerative disorders like Huntington disease.
-
Biogen and Eisai claim mid-stage win for Alzheimer’s drug
This is the first late-stage anti-amyloid antibody study to successfully achieve statistically significant results at 18 months, further validating the amyloid hypothesis,” said Eisai’s head of neurology Lynn
-
Lundbeck signs $1.1bn deal for Prexton and Parkinson’s drug
The Danish drugmaker is already a big player in neurology and psychological diseases, and PD is a core focus for the company which has suffered some pipeline setbacks of late, including
More from news
Approximately 5 fully matching, plus 126 partially matching documents found.
Latest Intelligence
-
Tackling a formidable foe
Ali-Frederic Ben-Amor, Vice President, Global Medical Affairs for Neurology &Immunology, Merck. ... Ali-Frederic Ben-Amor, Vice President, Global Medical Affairs for Neurology &Immunology, Merck, epitomises the field’s passion and refusal to take a
-
A quest for innovative solutions
Ecosystem. “I have the most beautiful job in the company because my team and I are exposed to the change externally,” says Erik Janssen, UCB’s head of innovative solutions, Neurology
-
The good, the bad and the ugly
Biogen was the largest seller in the CNS market in 2017 and this is forecast to continue,” says Rahael Maladwala, analyst, neurology and ophthalmology, GlobalData. ... Neurology experienced slow growth, largely because few diseases are very well
-
Deal Watch October 2016
$330m. Neurology 2016. Aspen. 5 anesthetics. $770m royalties. $592m. 1.3. Neurology 2014. ... Lilly. AZD3293. $500 profit share. Neurology 2012. Impax US. Zomig US.
-
Deal Watch August 2016
So the product, which is an orphan drug, ended up in the portfolio of a $10bn company focussed on GI, dermatology and neurology and which was under investigation by the SEC
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Axovant poaches Allergan’s and Teva’s chief medical and science officers
Corcoran’s career history has seen him supervise drug development across multiple therapeutic areas including neurology and psychiatry.
-
Topas Therapeutics appoints chief development officer and chief medical officer
vice president, multiple sclerosis/neurology and immunology.
-
GW Pharmaceuticals strengthens research and development team
Volker has an impressive record of successful new drug development and obtaining regulatory approvals which together with his deep experience in neurology, makes him ideally suited to lead GW’s clinical
-
Sam Agus takes up new role at Hansa Medical
Agus has previously held various leading positions at several pharmaceutical companies includingAbbott Laboratories and most recently at H.Lundbeck A/S as it’s chief specialist, medical affairs neurology. ... With experience in medical strategy,
-
J&J’s clinical research neuroscience director joins MedAvante
He also brings extensive experience in psychiatry, neurology and dermatology, making him an ideal addition to MedAvante's scientific leadership team.”.
More from appointments
Approximately 0 fully matching, plus 30 partially matching documents found.
Latest from PMHub
-
Lucid Group welcomes new magical talent and boosts their medical writing teams with hires in the US and UK
Hazel Urwin joins Lucid Partners as a Scientific Director. Hazel has eight years’ experience in medical communications with particular expertise in the fields of neurology, immunology and rheumatology.
-
PRMA Consulting Ltd
Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology,
-
Bringing the NHS into the 21st century
We have consultants specialising in cardiology, endocrine, ENT, gynaecology, haematology, neurology, respiratory, orthopaedics, rheumatology, and urology.
-
Lighthouse Medical Communications US bolster their senior scientific team
number of key therapeutic areas such endocrinology, neurology, oncology, hematology, women’s health and rare diseases.
-
THE OTHER SIDE OF … MULTIPLE SCLEROSIS
And for the past 15 years Robert has been by her side for every visit to the neurology department.
More from PMHub
Approximately 1 fully matching, plus 11 partially matching documents found.
Featured jobs
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Experienced Medical Writers
-
Competitive Salary and Benefits
-
Medical (Scientific) Director
-
£120, 000 benefits
-
Account Manager
-
Negotiable
- Principal Health Economist - North-West
-
Negotiable
- Business Development Director – Health Education
-
excellent commission
- Senior Account Executive with progression to Account Manager, Me...
-
Excellent package
-
Systematic Reviewer - Oxford
-
Negotiable
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Business Director
-
Competitive Salary Offered
-
Account Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
- Account Manager / Senior Account Manager
-
35, 000-40, 000
- Account Manager- Healthcare Advertising
-
Negotiable
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
-
Account Manager / Account Director
-
Competative
Subscribe to our email news alerts
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
- Combined immunotherapies – potential and pitfalls
- ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Quick links
Infographics
